Floatz logo

rg4733

Adult Anaplastic (Malignant) Meningioma

National Cancer Institute (NCI)Phase 1Dormant
C
38/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
23/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Adult Anaplastic (Malignant) Meningioma cohort.

Asset / SponsorPhaseRating
Ribociclib
St. Jude Children's Research Hospital
Phase 1CC
FILGRASTIM
St. Jude Children's Research Hospital
Phase 1CC
Therapeutic Allogeneic Lymphocytes
City of Hope Medical Center
Phase 1CC
gsk1120212
St. Jude Children's Research Hospital
Phase 1CC
Sonidegib
St. Jude Children's Research Hospital
Phase 1CC
ONC 206
Jazz Pharmaceuticals
Phase 1CC
Gadobutrol
University of Southern California
N/AD
GADOBENATE DIMEGLUMINE
University of Southern California
N/AD

Same molecule, other indications

rg4733 is also rated in:

non-small cell lung carcinomaDormant
CCC
Indicative ·
51 / 100
View asset →
melanomaDormant
CCC
Indicative ·
51 / 100
View asset →
Stage IV Skin MelanomaDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →